Source: BMC Cancer. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS (PROGNÓSTICO), ANTINEOPLÁSICOS, EXPRESSÃO GÊNICA
ABNT
TIEZZI, Daniel G. et al. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer, v. 7, n. 36, 2007Tradução . . Disponível em: https://doi.org/10.1186/1471-2407-7-36. Acesso em: 01 nov. 2024.APA
Tiezzi, D. G., Andrade, J. M. de, Ribeiro-Silva, A., Zola, F. E., Marana, H. R. C., & Tiezzi, M. G. (2007). HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer, 7( 36). doi:10.1186/1471-2407-7-36NLM
Tiezzi DG, Andrade JM de, Ribeiro-Silva A, Zola FE, Marana HRC, Tiezzi MG. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination [Internet]. BMC Cancer. 2007 ; 7( 36):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/1471-2407-7-36Vancouver
Tiezzi DG, Andrade JM de, Ribeiro-Silva A, Zola FE, Marana HRC, Tiezzi MG. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination [Internet]. BMC Cancer. 2007 ; 7( 36):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/1471-2407-7-36